Biotechnology Assets, S.A. (BST:041)
0.180
-0.030 (-14.29%)
At close: Dec 5, 2025
Biotechnology Assets Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -2.08 | -2.92 | 1.57 | -1.94 | -3.01 | -8.61 | Upgrade
|
| Depreciation & Amortization | 0.34 | 1 | 1.01 | 1.03 | 1.03 | 1.04 | Upgrade
|
| Other Amortization | 1.73 | 1.21 | 1.45 | 1.12 | 1 | 1.17 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.52 | 0.52 | 0.05 | - | 0.06 | 1.66 | Upgrade
|
| Other Operating Activities | 0.86 | 0.44 | -3.57 | -0.07 | -0.08 | 8.16 | Upgrade
|
| Change in Accounts Receivable | -0.63 | -0.46 | -1.02 | 0.37 | 0.06 | 13.12 | Upgrade
|
| Change in Inventory | - | - | - | - | 0.02 | 8.01 | Upgrade
|
| Change in Accounts Payable | -0.08 | 0.16 | 0.06 | -0.52 | -0.76 | -10.26 | Upgrade
|
| Change in Other Net Operating Assets | -0.08 | -0.03 | 0.47 | - | 0.18 | 1.41 | Upgrade
|
| Operating Cash Flow | 0.57 | -0.07 | 0.05 | -0.02 | -1.5 | 8.81 | Upgrade
|
| Capital Expenditures | -0.01 | -0.01 | -0.07 | -0.13 | -0.02 | -0 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | - | 44.84 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.45 | -0.71 | -0.26 | -1.99 | -0.64 | -0.39 | Upgrade
|
| Investment in Securities | - | - | - | - | - | 0.39 | Upgrade
|
| Other Investing Activities | 0 | - | - | - | - | - | Upgrade
|
| Investing Cash Flow | -0.47 | -0.72 | -0.33 | -2.12 | -0.66 | 44.84 | Upgrade
|
| Short-Term Debt Issued | - | 0.04 | - | - | 0.07 | - | Upgrade
|
| Long-Term Debt Issued | - | 1.52 | 0.59 | 0.59 | 0.73 | - | Upgrade
|
| Total Debt Issued | 0.84 | 1.56 | 0.59 | 0.59 | 0.8 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | -0.13 | -0.22 | - | -43.36 | Upgrade
|
| Long-Term Debt Repaid | - | -1.65 | -0.59 | -0.59 | -0.56 | -14.56 | Upgrade
|
| Total Debt Repaid | -2.07 | -1.65 | -0.72 | -0.81 | -0.56 | -57.93 | Upgrade
|
| Net Debt Issued (Repaid) | -1.22 | -0.09 | -0.13 | -0.22 | 0.24 | -57.93 | Upgrade
|
| Issuance of Common Stock | 1.27 | 0.9 | 0.51 | 1.51 | 3.01 | - | Upgrade
|
| Repurchase of Common Stock | - | -0.12 | -0.08 | -0.08 | -0.01 | - | Upgrade
|
| Other Financing Activities | -0.2 | -0.05 | -0.37 | -0.06 | 0.05 | 0.07 | Upgrade
|
| Financing Cash Flow | -0.15 | 0.64 | -0.06 | 1.15 | 3.28 | -57.86 | Upgrade
|
| Net Cash Flow | -0.04 | -0.16 | -0.34 | -0.99 | 1.12 | -4.21 | Upgrade
|
| Free Cash Flow | 0.56 | -0.09 | -0.02 | -0.14 | -1.52 | 8.8 | Upgrade
|
| Free Cash Flow Margin | 18.41% | -2.96% | -0.56% | -4.90% | -46.29% | 304.47% | Upgrade
|
| Free Cash Flow Per Share | - | -0.00 | - | -0.00 | -0.03 | 0.23 | Upgrade
|
| Cash Interest Paid | 0.13 | 0.13 | 0.07 | 0.13 | 0.53 | 0.18 | Upgrade
|
| Cash Income Tax Paid | - | - | - | 0.02 | 0.11 | 0.02 | Upgrade
|
| Levered Free Cash Flow | -0.33 | 0.35 | 2.5 | -0.97 | -1.77 | 9.87 | Upgrade
|
| Unlevered Free Cash Flow | -0.22 | 0.46 | 2.69 | -0.76 | -1.24 | 10.08 | Upgrade
|
| Change in Working Capital | -0.79 | -0.32 | -0.48 | -0.15 | -0.5 | 12.28 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.